Pacific Biosciences of California Inc. Reaches New 12-Month High at $6.97 (PACB)
Pacific Biosciences of California (NASDAQ:PACB)’s share price reached a new 52-week high during trading on Friday, ARN reports. The stock traded as high as $6.97 and last traded at $6.94, with a volume of 2,107,858 shares traded. The stock had previously closed at $5.68.
Pacific Biosciences of California has a one year low of $1.95 and a one year high of $6.50. The stock’s 50-day moving average is $4.92 and its 200-day moving average is $4.12. The company’s market cap is $431.3 million.
Pacific Biosciences of California (NASDAQ:PACB) last announced its earnings results on Tuesday, October 22nd. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.01. The company had revenue of $7.40 million for the quarter, compared to the consensus estimate of $7.08 million. During the same quarter in the previous year, the company posted ($0.41) earnings per share. The company’s revenue for the quarter was up 164.3% on a year-over-year basis. Analysts expect that Pacific Biosciences of California will post $-1.25 EPS for the current fiscal year.
Pacific Biosciences, Inc develops Deoxyribonucleic Acid (NASDAQ:PACB) sequencing platform.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.